![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Elysee Development Corp (PK) | USOTC:ASXSF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.23824 | 0.193 | 0.2707 | 0.00 | 14:06:12 |
Nevada
|
001-15975
|
86-0837251
|
(State
or Other Jurisdiction of
|
(Commission
File Number)
|
(IRS
Employer
|
Incorporation)
|
Identification
No.)
|
Xavier de Cocklaan 42, 9831, Deurle,
Belgium
|
N/A
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
(d)
|
Exhibits
.
|
Exhibit No.
|
Exhibit Description
|
|
99.1
|
|
Press
Release dated November 17,
2009
|
REMEDENT,
INC.,
|
||
a
Nevada corporation
|
||
Dated:
November 17, 2009
|
By:
|
/s/
Stephen
Ross
|
Stephen
Ross
|
||
Chief
Financial Officer
|
1 Year Elysee Development (PK) Chart |
1 Month Elysee Development (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions